"Prevalence" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
| Descriptor ID |
D015995
|
| MeSH Number(s) |
E05.318.308.985.525.750 N01.224.935.597.750 N06.850.505.400.975.525.750 N06.850.520.308.985.525.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Prevalence".
Below are MeSH descriptors whose meaning is more specific than "Prevalence".
This graph shows the total number of publications written about "Prevalence" by people in this website by year, and whether "Prevalence" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 6 | 6 |
| 1997 | 0 | 6 | 6 |
| 1998 | 0 | 6 | 6 |
| 1999 | 0 | 12 | 12 |
| 2000 | 0 | 12 | 12 |
| 2001 | 0 | 14 | 14 |
| 2002 | 0 | 14 | 14 |
| 2003 | 0 | 18 | 18 |
| 2004 | 0 | 22 | 22 |
| 2005 | 0 | 21 | 21 |
| 2006 | 0 | 33 | 33 |
| 2007 | 0 | 31 | 31 |
| 2008 | 0 | 44 | 44 |
| 2009 | 0 | 29 | 29 |
| 2010 | 0 | 24 | 24 |
| 2011 | 0 | 47 | 47 |
| 2012 | 0 | 46 | 46 |
| 2013 | 0 | 36 | 36 |
| 2014 | 0 | 53 | 53 |
| 2015 | 0 | 47 | 47 |
| 2016 | 0 | 53 | 53 |
| 2017 | 0 | 62 | 62 |
| 2018 | 0 | 70 | 70 |
| 2019 | 0 | 61 | 61 |
| 2020 | 0 | 69 | 69 |
| 2021 | 0 | 57 | 57 |
| 2022 | 0 | 29 | 29 |
| 2023 | 0 | 30 | 30 |
| 2024 | 0 | 46 | 46 |
| 2025 | 0 | 29 | 29 |
| 2026 | 0 | 18 | 18 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prevalence" by people in Profiles.
-
Brief Report: Detectable Coronary Artery Score Among People Living With HIV With Regional, Study, and Population Variations: A Systematic Review and Meta-Analysis. J Acquir Immune Defic Syndr. 2026 Aug 01; 101(8):913-921.
-
Prevalence and Distribution of Goiter Among Commercially Insured, Working-Age Adults in the United States. Thyroid. 2026 Sep; 36(9):1026-1030.
-
A systematic review and meta-analysis of elevated lipoprotein(a) and adverse limb outcomes in peripheral artery disease after revascularization. J Vasc Surg. 2026 Sep; 84(3):671-685.e5.
-
Placental pathology in pregnancies complicated by hypertensive disorders of pregnancy and small for gestational age neonates: prevalence and severity of maternal vascular malperfusion in a prospectively collected cohort. J Matern Fetal Neonatal Med. 2026 Dec; 39(1):2669893.
-
Hearing/vestibular problems, racial differences, and associations with physical function impairment among breast cancer survivors. JNCI Cancer Spectr. 2026 May 09; 10(3).
-
Recruitment of Minority Patients in Metabolic Dysfunction-Associated Steatotic Liver Disease Clinical Trials. Dig Dis Sci. 2026 Sep; 71(9):4235-4241.
-
Diabetes Mellitus and Recurrent Urinary Tract Infections. Urogynecology (Phila). 2026 May 01; 32(5):477-485.
-
Social Determinants of Cardiovascular Disease Risk Factors Among Black Ethnic Groups: Findings From the 2013 to 2018 National Health Interview Survey. J Am Heart Assoc. 2026 04 21; 15(8):e047268.
-
Implementation and evaluation of a pragmatic community streptococcal treatment programme to improve rheumatic heart disease primary prevention in Uganda. BMJ Glob Health. 2026 04 09; 11(4).
-
Anal Cancer Screening Prevalence in U.S. Cities and Factors Associated With Screening. Am J Prev Med. 2026 Sep; 71(3):108373.